POTASSIUM CHLORIDE IN SODIUM CHLORIDE INJECTION USP SOLUTION

Negara: Kanada

Bahasa: Inggris

Sumber: Health Canada

Bahan aktif:

SODIUM CHLORIDE; POTASSIUM CHLORIDE

Tersedia dari:

BAXTER CORPORATION

Kode ATC:

B05BB01

INN (Nama Internasional):

ELECTROLYTES

Dosis:

450MG; 150MG

Bentuk farmasi:

SOLUTION

Komposisi:

SODIUM CHLORIDE 450MG; POTASSIUM CHLORIDE 150MG

Rute administrasi :

INTRAVENOUS

Unit dalam paket:

1000ML

Jenis Resep:

Ethical

Area terapi:

REPLACEMENT PREPARATIONS

Ringkasan produk:

Active ingredient group (AIG) number: 0213340004; AHFS:

Status otorisasi:

MARKETED

Tanggal Otorisasi:

2008-03-31

Karakteristik produk

Potassium Chloride in 0.45% Sodium Chloride Injection, USP Prescribing
Information
_ _
_Page 1 of 14_
PRESCRIBING INFORMATION
POTASSIUM CHLORIDE IN 0.45% SODIUM CHLORIDE INJECTION, USP
IN PLASTIC CONTAINER
VIAFLEX
Container
20 mmol/L Potassium Chloride in 0.45% Sodium Chloride Injection
SOLUTION FOR INFUSION
Solutions Affecting the Electrolyte Balance
BAXTER CORPORATION
Mississauga, ON L5N 0C2
Date of Revision:
December 10, 2018
Control No. 221539
Potassium Chloride in 0.45% Sodium Chloride Injection, USP Prescribing
Information
_ _
_Page 2 of 14_
TABLE OF CONTENTS
SUMMARY PRODUCT INFORMATION
....................................................................................3
INDICATIONS AND CLINICAL USE
..........................................................................................3
CONTRAINDICATIONS
...............................................................................................................3
WARNINGS AND PRECAUTIONS
..............................................................................................3
SPECIAL POPULATIONS
.............................................................................................................7
ADVERSE REACTIONS
................................................................................................................8
DRUG INTERACTIONS
................................................................................................................8
DOSAGE AND ADMINISTRATION
............................................................................................9
INSTRUCTIONS FOR USE AND HANDLING AND DISPOSAL
............................................10
DIRECTIONS FOR USE OF VIAFLEX PLUS PLASTIC CONTAINER
..................................11
OVERDOSE
..................................................................................................................................12
ACTION AND CLINICAL PHARMACOLOGY
........................................................................13
STORAGE AND STABILITY
..................